DOI QR코드

DOI QR Code

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome

  • Chang, Hye Jin (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Kim, Hwa Young (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Choi, Jae Hong (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Choi, Hyun Jin (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Ko, Jae Sung (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Ha, Il Soo (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Cheong, Hae Il (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Choi, Yong (Department of Pediatrics, Seoul National University College of Medicine) ;
  • Kang, Hee Gyung (Department of Pediatrics, Seoul National University College of Medicine)
  • 투고 : 2012.08.24
  • 심사 : 2012.10.18
  • 발행 : 2014.02.15

초록

Hemolytic uremic syndrome (HUS) is one of the most common causes of acute renal failure in childhood and is primarily diagnosed in up to 4.5% of children who undergo chronic renal replacement therapy. Escherichia coli serotype O157:H7 is the predominant bacterial strain identified in patients with HUS; more than 100 types of Shiga toxin-producing enterohemorrhagic E. coli (EHEC) subtypes have also been isolated. The typical HUS manifestations are microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency. In typical HUS cases, more serious EHEC manifestations include severe hemorrhagic colitis, bowel necrosis and perforation, rectal prolapse, peritonitis, and intussusceptions. Colonic perforation, which has an incidence of 1%-2%, can be a fatal complication. In this study, we report a typical Shiga toxin-associated HUS case complicated by small intestinal perforation with refractory peritonitis that was possibly because of ischemic enteritis. Although the degree of renal damage is the main concern in HUS, extrarenal complications should also be considered in severe cases, as presented in our case.

키워드

참고문헌

  1. Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008;23:1749-60. https://doi.org/10.1007/s00467-008-0935-6
  2. Verweyen HM, Karch H, Brandis M, Zimmerhackl LB. Enterohemorrhagic Escherichia coli infections: following transmission routes. Pediatr Nephrol 2000;14:73-83. https://doi.org/10.1007/s004670050018
  3. de Buys Roessingh AS, de Lagausie P, Baudoin V, Loirat C, Aigrain Y. Gastrointestinal complications of post-diarrheal hemolytic uremic syndrome. Eur J Pediatr Surg 2007;17:328-34. https://doi.org/10.1055/s-2007-965013
  4. Rahman RC, Cobenas CJ, Drut R, Amoreo OR, Ruscasso JD, Spizzirri AP, et al. Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children. Pediatr Nephrol 2012;27:229-33. https://doi.org/10.1007/s00467-011-1973-z
  5. Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 1994;125:511-8. https://doi.org/10.1016/S0022-3476(94)70001-X
  6. Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988;19:1102-8. https://doi.org/10.1016/S0046-8177(88)80093-5
  7. Keenan KP, Sharpnack DD, Collins H, Formal SB, O'Brien AD. Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. Am J Pathol 1986;125:69-80.
  8. Pai CH, Kelly JK, Meyers GL. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun 1986;51:16-23.
  9. Brandt ML, O'Regan S, Rousseau E, Yazbeck S. Surgical complications of the hemolytic-uremic syndrome. J Pediatr Surg 1990;25: 1109-12. https://doi.org/10.1016/0022-3468(90)90741-Q
  10. Crabbe DC, Broklebank JT, Spicer RD. Gastrointestinal complications of the haemolytic uraemic syndrome. J R Soc Med 1990; 83:773-5.
  11. de la Hunt MN, Morris KP, Coulthard MG, Rangecroft L. Oesophageal and severe gut involvement in the haemolytic uraemic syndrome. Br J Surg 1991;78:1469-72. https://doi.org/10.1002/bjs.1800781220
  12. Tapper D, Tarr P, Avner E, Brandt J, Waldhausen J. Lessons learned in the management of hemolytic uremic syndrome in children. J Pediatr Surg 1995;30:158-63. https://doi.org/10.1016/0022-3468(95)90554-5